Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shingo Nagano is active.

Publication


Featured researches published by Shingo Nagano.


Journal of Biological Chemistry | 2004

Crystal structure of the cytochrome p450cam mutant that exhibits the same spectral perturbations induced by putidaredoxin binding.

Shingo Nagano; Takehiko Tosha; Koichiro Ishimori; Isao Morishima; Thomas L. Poulos

The cytochrome P450cam active site is known to be perturbed by binding to its redox partner, putidaredoxin (Pdx). Pdx binding also enhances the camphor monooxygenation reaction (Nagano, S., Shimada, H., Tarumi, A., Hishiki, T., Kimata-Ariga, Y., Egawa, T., Suematsu, M., Park, S.-Y., Adachi, S., Shiro, Y., and Ishimura, Y. (2003) Biochemistry 42, 14507–14514). These effects are unique to Pdx because nonphysiological electron donors are unable to support camphor monooxygenation. The accompanying 1H NMR paper (Tosha, T., Yoshioka, S., Ishimori, K., and Morishima, I. (2004) J. Biol. Chem. 279, 42836–42843) shows that the conformation of active site residues, Thr-252 and Cys-357, and the substrate in the ferrous (Fe(II)) CO complex of the L358P mutant mimics that of the wild-type enzyme complexed to Pdx. To explore how these changes are transmitted from the Pdx-binding site to the active site, we have solved the crystal structures of the ferrous and ferrous-CO complex of wild-type and the L358P mutant. Comparison of these structures shows that the L358P mutation results in the movement of Arg-112, a residue known to be important for putidaredoxin binding, toward the heme. This change could optimize the Pdx-binding site leading to a higher affinity for Pdx. The mutation also pushes the heme toward the substrate and ligand binding pocket, which relocates the substrate to a position favorable for regio-selective hydroxylation. The camphor is held more firmly in place as indicated by a lower average temperature factor. Residues involved in the catalytically important proton shuttle system in the I helix are also altered by the mutation. Such conformational alterations and the enhanced reactivity of the mutant oxy complex with non-physiological electron donors suggest that Pdx binding optimizes the distal pocket for monooxygenation of camphor.


Journal of Inorganic Biochemistry | 2001

Putidaredoxin-cytochrome P450cam interaction.

Hideo Shimada; Shingo Nagano; Hiroshi Hori; Yuzuru Ishimura

Cytochrome P450cam (P450cam) catalyzes the monooxygenation of D-camphor. During the enzymatic reaction, oxyferrous, D-camphor-bound P450cam forms a binary complex with reduced putidaredoxin as an obligatory reaction intermediate. We have found that reduced putidaredoxin undergoes EPR-detectable conformational changes upon formation of the intermediate complex and also upon formation of a binary complex with CO- or NO-ferrous, D-camphor-bound P450cam. The structural changes in putidaredoxin are almost identical irrespective of the ligand bound to P450cam, and distinct from and significantly larger than those induced by unliganded ferrous P450cam. The binary complex formation also induce conformational alterations in the CO- and NO-ferrous, D-camphor-bound P450cam, thereby evoking simultaneous changes in the structure of the two proteins. A molecular basis and roles of such structural changes in the D-camphor monooxygenation are discussed.


Journal of Biological Chemistry | 1999

Putidaredoxin-cytochrome p450cam interaction. Spin state of the heme iron modulates putidaredoxin structure.

Hideo Shimada; Shingo Nagano; Yoko Ariga; Masashi Unno; Tsuyoshi Egawa; Takako Hishiki; Yuzuru Ishimura; Futoshi Masuya; Takashi Obata; Hiroshi Hori

During the monooxygenase reaction catalyzed by cytochrome P450cam (P450cam), a ternary complex of P450cam, reduced putidaredoxin, andd-camphor is formed as an obligatory reaction intermediate. When ligands such as CO, NO, and O2 bind to the heme iron of P450cam in the intermediate complex, the EPR spectrum of reduced putidaredoxin with a characteristic signal at 346 millitesla at 77 K changed into a spectrum having a new signal at 348 millitesla. The experiment with O2 was carried out by employing a mutant P450cam with Asp251 → Asn or Gly where the rate of electron transfer from putidaredoxin to oxyferrous P450cam is considerably reduced. Such a ligand-induced EPR spectral change of putidaredoxin was also shown in situ inPseudomonas putida. Mutations introduced into the neighborhood of the iron-sulfur cluster of putidaredoxin revealed that a Ser44 → Gly mutation mimicked the ligand-induced spectral change of putidaredoxin. Arg109 and Arg112, which are in the putative putidaredoxin binding site of P450cam, were essential for the spectral changes of putidaredoxin in the complex. These results indicate that a change in the P450cam active site that is the consequence of an altered spin state is transmitted to putidaredoxin within the ternary complex and produces a conformational change of the 2Fe–2S active center.


International Congress Series | 2002

Subunit structure of recombinant rat liver l-tryptophan 2,3-dioxygenase

Surya Prasad Manandhar; Hideo Shimada; Shingo Nagano; Tsuyoshi Egawa; Yuzuru Ishimura

Abstract Rat liver l -tryptophan 2,3-dioxygenase (TDO) with a histidine tag at the N-terminus was expressed in Escherichia coli JM109 harboring plasmid pUC18 carrying the full-length cDNA of TDO. The recombinant enzyme was purified to near homogeneity by employing conventional purification methods including nickel-chelate immobilized resin column chromatography. The purified enzyme had a turnover number per heme 303 min −1 with similar spectral properties to those of native rat liver enzyme. SDS-PAGE of purified TDO preparation showed two distinct bands with molecular masses of 49 and 46 kDa. N-terminal sequence analysis of the components revealed that the 46-kDa species is shorter than the 49-kDa one by 19 amino acid residues including six histidine residues at the end. Thus, a limited proteolysis appeared to occur between Tyr 13 and Thr 14 of the original polypeptide chain. The construct of recombinant TDO with deletion of the N-terminal 13 residues gave a single band on SDS-PAGE with a molecular mass of about 46 kDa. The N-terminal truncation had no effect on the catalytic activity nor on the spectral properties.


Nihon Kessho Gakkaishi | 2006

Molecular Mechanism of Metal-Containing Oxygenases

Hiroshi Sugimoto; Shingo Nagano; Yoshitsugu Shiro

Over a past few years, we have determined crystal structures of several metal-containing oxygenases including indoleamin-2, 3-dioxygenase and some P450s which have interesting chemistry and play important roles in metabolism. Molecular mechanisms of these oxygenases are discussed based on the crystal structures.


Journal of Biological Chemistry | 2005

Crystallographic Study on the Dioxygen Complex of Wild-type and Mutant Cytochrome P450cam IMPLICATIONS FOR THE DIOXYGEN ACTIVATION MECHANISM

Shingo Nagano; Thomas L. Poulos


Biochemistry | 2003

Infrared spectroscopic and mutational studies on putidaredoxin-induced conformational changes in ferrous CO-P450cam

Shingo Nagano; Hideo Shimada; Akiko Tarumi; Takako Hishiki; Yoko Kimata-Ariga; Tsuyoshi Egawa; Makoto Suematsu; Sam-Yong Park; Shin-ichi Adachi; Yoshitsugu Shiro; Yuzuru Ishimura


Journal of Biochemistry | 2000

X-ray crystal structure and catalytic properties of Thr252Ile mutant of cytochrome P450cam: roles of Thr252 and water in the active center.

Takako Hishiki; Hideo Shimada; Shingo Nagano; Tsuyoshi Egawa; Y. Kanamori; Ryu Makino; Sam-Yong Park; S. I. Adachi; Y. Shiro; Yuzuru Ishimura


Journal of Biological Chemistry | 2003

Kinetic and spectroscopic characterization of a hydroperoxy compound in the reaction of native myoglobin with hydrogen peroxide.

Tsuyoshi Egawa; Shiro Yoshioka; Satoshi Takahashi; Hiroshi Hori; Shingo Nagano; Hideo Shimada; Koichiro Ishimori; Isao Morishima; Makoto Suematsu; Yuzuru Ishimura


生物物理 | 2013

3P005 仮性結核菌由来ヘム獲得蛋白質HasAの結晶構造解析による新規ヘム結合様式の解明(01A.蛋白質:構造,ポスター,日本生物物理学会年会第51回(2013年度))

Masahiro Kanadani; Toshiki Muroki; Yukie Ishimaru; Saki Wada; Takehiro Sato; Shin-ichi Ozaki; Tomoya Hino; Shingo Nagano

Collaboration


Dive into the Shingo Nagano's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tsuyoshi Egawa

Albert Einstein College of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge